Enabling Child and Adolescent Mental Health Services (CAMHS) to provide efficient remote treatment for child anxiety problems in the COVID-19 context

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:3 publications

Grant number: MR/V028510/1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $327,259.8
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Professor Cathy Creswell
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Oxford
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    Innovation

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adolescent (13 years to 17 years)Adults (18 and older)Children (1 year to 12 years)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This proposal addresses the need for evaluation of innovations in health and social care delivery prompted by the pandemic which can be generalised and actioned in the pandemic context. Specifically this proposal sets out to mitigate the impact of the COVID19 outbreak on children, families and Child and Adolescent Mental Health Services (CAMHS) by evaluating an innovative, potentially cost-effective, digital intervention for child anxiety problems. The focus is on child anxiety problems because (i) they are the most common mental health problem across the lifespan, (ii) they typically first occur in childhood and are a common reason for referral to CAMHS, (iii) fears, worries, and anxieties have been fuelled by the current context which has increased perceptions of threat and uncertainty, and (iv) CAMHS have identified children with anxiety problems as a key risk group in the context of COVID-19- both during lockdown and as social distancing measures are relaxed. We will conduct a multi-site randomised non-inferiority trial to establish whether a novel online, parent-led cognitive behavior therapy program (OSI; Online Support and Intervention for child anxiety) is as effective as what CAMHS are currently delivering in the COVID-19 context, and whether it brings health-economic benefits. This research has the potential to provide (i) a solution for efficient psychological treatment for child anxiety disorders while social distancing, (ii) an efficient means of treatment delivery to manage the anticipated increase in CAMHS referrals when social distancing measures are relaxed and schools reopen, and will (iii) pave the way for high quality, efficient evaluation and implementation of digital solutions in CAMHS.

Publicationslinked via Europe PMC

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial.

A randomised controlled trial to compare clinical and cost-effectiveness of an online parent-led treatment for child anxiety problems with usual care in the context of COVID-19 delivered in Child and Adolescent Mental Health Services in the UK (Co-CAT): a study protocol for a randomised controlled trial.

Mitigating the impacts of COVID-19: where are the mental health trials?